CDK4/6 inhibitors: basics, pros, and major cons in breast cancer treatment with specific regard to cardiotoxicity - a narrative review - Pavlovic, D; Niciforovic, D; Papic, D; Milojevic, K; Markovic, M
Ther Adv Med Oncol 2023;15:17588359231205848